HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Patent Cooperation Treaty
PCT/US2021/017852
Filed on 2021-02-12
PCT/US2021/017852
Filed on 2021-02-12
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION
Patent Cooperation Treaty
PCT/US2021/017794
Filed on 2021-02-12
PCT/US2021/017794
Filed on 2021-02-12
CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE
Japan
2021-3261
Filed on 2017-09-20
2021-3261
Filed on 2017-09-20
TASPASE1 INHIBITORS AND USES THEREOF
Patent Cooperation Treaty
PCT/US2020/061657
Filed on 2020-11-20
PCT/US2020/061657
Filed on 2020-11-20
ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS
US Patent 11,697,676
Filed on 2021-01-06
Filed on 2021-01-06
AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF
US Patent 11,939,377
Filed on 2021-01-11
Filed on 2021-01-11
AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF
Japan
2021-500651
Filed on 2019-07-11
2021-500651
Filed on 2019-07-11
AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF
European Patent
19746264.1
Filed on 2019-07-11
19746264.1
Filed on 2019-07-11
Affinity Matured M971 For CD22 Positive Cancer Therapeutics Development
Canada
3105694
Filed on 2019-07-11
3105694
Filed on 2019-07-11
AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF
Australia
2019301675
Filed on 2019-07-11
2019301675
Filed on 2019-07-11